ClinicalTrials.Veeva

Menu

Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Completed

Conditions

Pulmonary Aspiration

Treatments

Diagnostic Test: Gastric ultrasound

Study type

Observational

Funder types

Other

Identifiers

NCT05889637
HSC-MS-23-0300

Details and patient eligibility

About

The purpose of this study is to determine the type of gastric content and quantify the volume of liquid gastric contents using ultrasonography in patients on GLP-1 agonists that have presented for elective surgery and to determine if risk factors are associated with a higher gastric volume in patients on GLP-1 receptor agonists.

Enrollment

132 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients taking GLP-1receptor agonists (N=62)
  • Patients not taking GLP-1 receptor agonists (N=62)

Exclusion criteria

  • Previous gastric resection or bypass
  • Gastric band in situ
  • Previous fundoplication
  • Large hiatal hernia
  • Pregnant patients
  • Recent trauma
  • Inability to turn to the right lateral decubitus position

Trial design

132 participants in 2 patient groups

Group G: Patients taking GLP-1receptor agonists
Treatment:
Diagnostic Test: Gastric ultrasound
Group C: Patients not taking GLP-1 receptor agonists (control group)
Treatment:
Diagnostic Test: Gastric ultrasound

Trial contacts and locations

1

Loading...

Central trial contact

Sudipta Sen, MD,FASA; Omonele Nwokolo

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems